Veeva Systems (NYSE:VEEV - Get Free Report) updated its third quarter 2025 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 1.570-1.580 for the period, compared to the consensus estimate of 1.580. The company issued revenue guidance of $682.0 million-$685.0 million, compared to the consensus revenue estimate of $685.7 million.
Analyst Upgrades and Downgrades
A number of research firms have commented on VEEV. Robert W. Baird reduced their price objective on shares of Veeva Systems from $251.00 to $245.00 and set an "outperform" rating on the stock in a research note on Monday, October 28th. Barclays increased their target price on shares of Veeva Systems from $240.00 to $260.00 and gave the stock an "overweight" rating in a report on Friday. Raymond James increased their target price on shares of Veeva Systems from $230.00 to $235.00 and gave the stock an "outperform" rating in a report on Thursday, August 29th. UBS Group increased their target price on shares of Veeva Systems from $185.00 to $215.00 and gave the stock a "neutral" rating in a report on Monday, August 26th. Finally, Truist Financial increased their target price on shares of Veeva Systems from $197.00 to $207.00 and gave the stock a "hold" rating in a report on Tuesday, September 3rd. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $237.00.
Get Our Latest Research Report on VEEV
Veeva Systems Trading Up 0.4 %
Shares of VEEV traded up $1.02 during midday trading on Monday, hitting $236.02. The stock had a trading volume of 556,209 shares, compared to its average volume of 941,846. Veeva Systems has a fifty-two week low of $162.85 and a fifty-two week high of $240.68. The business has a 50-day simple moving average of $213.98 and a two-hundred day simple moving average of $199.74. The firm has a market cap of $38.22 billion, a P/E ratio of 62.67, a price-to-earnings-growth ratio of 2.29 and a beta of 0.81.
Veeva Systems (NYSE:VEEV - Get Free Report) last posted its quarterly earnings results on Wednesday, August 28th. The technology company reported $1.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.04 by $0.03. The business had revenue of $676.18 million during the quarter, compared to analyst estimates of $667.21 million. Veeva Systems had a net margin of 23.91% and a return on equity of 13.30%. On average, analysts expect that Veeva Systems will post 4.21 earnings per share for the current fiscal year.
Insider Activity at Veeva Systems
In related news, SVP Jonathan Faddis sold 2,353 shares of the firm's stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $200.00, for a total transaction of $470,600.00. Following the transaction, the senior vice president now owns 9,035 shares of the company's stock, valued at approximately $1,807,000. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 10.50% of the company's stock.
Veeva Systems Company Profile
(
Get Free Report)
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Recommended Stories
Before you consider Veeva Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.
While Veeva Systems currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.